Completed

PANTHERPantoprazole 20 mg/40 mg for the Treatment of Gastroesophageal Reflux Disease (GERD)

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Non-Erosive Reflux Disease+4

+ Deglutition Disorders

+ Digestive System Diseases

Over 12 Years
1 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Case-Only

Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.
Observational
Study Start: October 2007
See protocol details

Summary

Principal SponsorNycomed
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: October 1, 2007

Actual date on which the first participant was enrolled.

The aim of the study was to evaluate the effect of 7 days treatment with Pantoprazole 40 mg and 20 mg on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) in clinical practice. During the study, the patients had to complete a short version of a patient-orientated, self-assessed reflux questionnaire (ReQuest™ in Practice).

Official TitlePantoprazole 20 mg/40 mg for the Treatment of Gastroesophageal Reflux Disease (GERD)
NCT00561730
Principal SponsorNycomed
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

1995 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Case-only

These studies focus only on individuals who have a specific disease. Researchers examine patterns—often genetic or environmental—to uncover what might be linked to the condition.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 12 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Non-Erosive Reflux DiseaseDeglutition DisordersDigestive System DiseasesEsophageal DiseasesGastroesophageal RefluxGastrointestinal DiseasesEsophageal Motility Disorders

Criteria

1 exclusion criteria prevent from participating
Criteria as defined in the Summary of Product Characteristics (Chapter 4.3)

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 259 locations

Suspended

Nycomed Deutschland GmbH

Aachen, GermanyOpen Nycomed Deutschland GmbH in Google Maps
Suspended

Nycomed Deutschland GmbH

Ahrensburg, Germany
Suspended

Nycomed Deutschland GmbH

Alfeld, Germany
Suspended

Nycomed Deutschland GmbH

Altenburg, Germany
Completed259 Study Centers